Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Disclosures
- History (1)
- Dr. Alvan Barach (1)
- Dr. Alvan Barach (2)
- Dr. Alvan Barach (3)
- History (2)
- Pulmonary rehabilitation for COPD (1)
- Pulmonary rehabilitation for COPD (2)
- The roots of pulmonary rehabilitation
- Establishing a physiologic basis for pulmonary rehabilitation
- Targets for improving exercise tolerance in pulmonary rehabilitation
- Muscle dysfunction
- Unequivocal benefits in COPD (1)
- Comparison of rehabilitation and bronchodilator on constant work rate exercise tolerance in COPD
- Unequivocal benefits in COPD (2)
- Pulmonary rehabilitation in COPD (1)
- Unequivocal benefits in COPD (3)
- Pulmonary rehabilitation after hospitalization for COPD: the PROPEL study (1)
- The PROPEL study: design features
- Pulmonary rehabilitation after hospitalization for COPD: the PROPEL study (2)
- An alternate approach
- Peter Lindenauer’s study (1)
- Peter Lindenauer’s study (2)
- Therapies that improve mortality in COPD
- Pulmonary rehabilitation in COPD (2)
- More from Peter Lindenauer (1)
- More from Peter Lindenauer (2)
- Propensity-matched analysis
- Pulmonary rehabilitation in COPD (3)
- Abysmal participation (1)
- Abysmal participation (2)
- Abysmal participation (3)
- Abysmal participation (4)
- Pulmonary rehabilitation in COPD (4)
- Strategies to improve participation in pulmonary rehabilitation (1)
- Marketing: to patients and providers - livebetter.org
- COPDfoundation.org
- Marketing: to insurers and regulators (1)
- Marketing: to insurers and regulators (2)
- Strategies to improve participation in pulmonary rehabilitation (2)
- Rehabilitation reimbursement in the US
- Strategies to improve participation in pulmonary rehabilitation (3)
- Strategies to improve participation in pulmonary rehabilitation (4)
- Home-based rehabilitation (1)
- Home-based rehabilitation (2)
- All home rehabilitation programs are not created equal
- Crucial considerations for remote rehabilitation
- Pulmonary rehabilitation in COPD (5)
Topics Covered
- The history of pulmonary rehabilitation
- Pulmonary rehabilitation for COPD
- Targets for improving exercise tolerance in pulmonary rehabilitation
- The PROPEL study
- Peter Lindenauer’s study
- Therapies that improve mortality in COPD
- Abysmal participation
- Strategies to improve participation
- Home-based rehabilitation
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Casaburi, R. (2022, July 31). Pulmonary rehabilitation: history, promise and problems [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 12, 2024, from https://doi.org/10.69645/ZTEW9562.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Richard Casaburi has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Pulmonary rehabilitation: history, promise and problems
Published on July 31, 2022
25 min
A selection of talks on Physiology & Anatomy
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. This is Richard Casaburi.
I'm a research scientist at
the Lundquist Institute
for Biomedical Innovation
at Harbor-UCLA Medical Center
in the Los Angeles
area of California.
I'm here today to
give you a lecture
on pulmonary rehabilitation:
history, promise and problems.
0:20
You'll see here my disclosures,
none of which are
relevant to this talk.
0:26
First, there is the history.
The image you'll see here
is of Dr. Alvan Barach,
who, as you'll see,
lived from 1895-1977.
I'd like to think of him as
the grandfather of
pulmonary rehabilitation.
0:41
Dr. Barach had a really
interesting career.
Starting in 1922, he
perfected the oxygen tent.
In 1934, he used heliox
in asthma and emphysema.
I was completely
unaware that this was
done any time in that era.
He investigated oral penicillin
for pneumonia in 1945.
In the early 1950s,
he developed portable
oxygen supplies
and used them in his patients.
He had 164 PubMed citations.
Remember, PubMed didn't
start until the 1990s.
These were all collected
in retrospect.
91 of them were as
the sole author
and 6 of them were published
in the year of his death.
He published several books.
1:26
I'd like to draw your
attention to this quote.
You have to realize
that in 1952,
the advice to COPD patients was
if you get shortness of
breath doing something,
well, stop doing it.
Here's what Dr. Barach said,
"In two patients with
pulmonary emphysema...
an exercise program
was instituted with
subsequent marked improvement
of capacity to exercise...
The progressive improvement
in ability to walk
without dyspnea suggested
that a physiological
response similar to a
training program in
athletes may have
been produced."
Again, a physiologic response.
This is what he was positing.